{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T12:09:50Z","timestamp":1782302990884,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.jsat.2016.07.014","type":"journal-article","created":{"date-parts":[[2016,8,11]],"date-time":"2016-08-11T14:35:17Z","timestamp":1470926117000},"page":"50-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["A Naturalistic Evaluation of Extended-Release Naltrexone in Clinical Practice in Missouri"],"prefix":"10.1016","volume":"70","author":[{"given":"Paul","family":"Crits-Christoph","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah M.","family":"Markell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Beth Connolly","family":"Gibbons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gallop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie","family":"Lundy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Stringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Gastfriend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2016.07.014_bb0005","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/pds.1673","article-title":"Goodness-of-fit diagnostics for the propensity score model when estimating treatment effects using covariate adjustment with the propensity score","volume":"17","author":"Austin","year":"2008","journal-title":"Pharmacoepidemiology Drug Safety"},{"key":"10.1016\/j.jsat.2016.07.014_bb0010","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1002\/sim.2328","article-title":"A comparison of propensity score methods: A case-study estimating the effectiveness of post-AMI statin use","volume":"25","author":"Austin","year":"2006","journal-title":"Statistics in Medicine"},{"key":"10.1016\/j.jsat.2016.07.014_bb0015","first-page":"S235","article-title":"Cost and utilization outcomes of opioid-dependence treatments","volume":"17","author":"Baser","year":"2011","journal-title":"American Journal of Managed Care"},{"key":"10.1016\/j.jsat.2016.07.014_bb0020","first-page":"S222","article-title":"Alcohol dependence treatments: Comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence","volume":"17","author":"Baser","year":"2011","journal-title":"American Journal of Managed Care"},{"key":"10.1016\/j.jsat.2016.07.014_bb0025","first-page":"S213","article-title":"Extended-release naltrexone for alcohol dependence: Persistence and healthcare costs and utilization","volume":"17","author":"Bryson","year":"2011","journal-title":"American Journal of Managed Care"},{"key":"10.1016\/j.jsat.2016.07.014_bb0030","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/ADM.0b013e3181c82207","article-title":"Impact of treatment with intramuscular, injectable, extended-release naltrexone on counseling and support group participation in patients with alcohol dependence","volume":"4","author":"Cisler","year":"2010","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.jsat.2016.07.014_bb0035","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/08897077.2011.609438","article-title":"A multisite pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationers","volume":"33","author":"Coviello","year":"2012","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2016.07.014_bb0040","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jsat.2015.03.003","article-title":"Extended-release naltrexone for alcohol and opioid problems in Missouri parolees and probationers","volume":"56","author":"Crits-Christoph","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2016.07.014_bb0045","series-title":"Analysis of observational health care data using SAS","author":"Faries","year":"2010"},{"key":"10.1016\/j.jsat.2016.07.014_bb0050","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jsat.2011.04.003","article-title":"Preliminary evaluation of extended-release naltrexone in Michigan and Missouri drug courts","volume":"41","author":"Finigan","year":"2011","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2016.07.014_bb0055","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jama.293.13.1617","article-title":"Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: A randomized controlled trial","volume":"293","author":"Garbutt","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jsat.2016.07.014_bb0060","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jsat.2015.07.005","article-title":"A phase 4, pilot, open-label study of VIVITROL\u00ae (extended-release naltrexone XR-NTX) for prisoners","volume":"59","author":"Gordon","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2016.07.014_bb0065","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jsat.2014.03.007","article-title":"Extended-release naltrexone for alcohol and opioid dependence: A meta-analysis of healthcare utilization studies","volume":"47","author":"Hartung","year":"2014","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2016.07.014_bb0070","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1198\/016214506000000447","article-title":"Evaluating kindergarten retention policy: A case study of causal inference for multilevel observational data","volume":"101","author":"Hong","year":"2006","journal-title":"Journal of the American Statistical Association"},{"key":"10.1016\/j.jsat.2016.07.014_bb0075","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1111\/acer.12557","article-title":"Estimating the efficacy of alcoholics anonymous without self-selection bias: An instrumental variables re-analysis of randomized clinical trials","volume":"38","author":"Humphreys","year":"2014","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/j.jsat.2016.07.014_bb0080","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1111\/j.1530-0277.2011.01523.x","article-title":"The efficacy of disulfiram for the treatment of alcohol use disorder","volume":"35","author":"J\u00f8rgensen","year":"2011","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/j.jsat.2016.07.014_bb0085","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/ADM.0b013e318262a97a","article-title":"Financial factors and the implementation of medications for treating opioid use disorders","volume":"6","author":"Knudsen","year":"2012","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.jsat.2016.07.014_bb0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/ADM.0b013e3181d41ddb","article-title":"Adoption and implementation of medications in addiction treatment programs","volume":"5","author":"Knudsen","year":"2011","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.jsat.2016.07.014_bb0095","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/j.1360-0443.2008.02345.x","article-title":"Persistence with oral naltrexone for alcohol treatment: Implications for health-care utilization","volume":"103","author":"Kranzler","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2016.07.014_bb0100","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0140-6736(11)60358-9","article-title":"Injectable extended-release naltrexone for opioid dependence: A double-blind, placebo-controlled, multicenter randomised trial","volume":"377","author":"Krupitsky","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jsat.2016.07.014_bb0105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/ADM.0b013e3181eb3b89","article-title":"Open-label pilot study of extended-release naltrexone to reduce drinking and driving among repeat offenders","volume":"5","author":"Lapham","year":"2011","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.jsat.2016.07.014_bb0110","first-page":"e125","article-title":"Extended-release naltrexone for opioid relapse prevention among opioid-dependent, criminal justice-involved adults","volume":"156","author":"Lee","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2016.07.014_bb0115","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"3","author":"Mattick","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jsat.2016.07.014_bb0120","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"Mattick","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jsat.2016.07.014_bb0125","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1002\/sim.5753","article-title":"A tutorial on propensity score estimation for multiple treatments using generalized boosted models","volume":"32","author":"McCaffrey","year":"2013","journal-title":"Statistics in Medicine"},{"key":"10.1016\/j.jsat.2016.07.014_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001333.pub3","article-title":"Oral naltrexone maintenance treatment for opioid dependence","volume":"13","author":"Minozzi","year":"2011","journal-title":"Cochrane Database Systematic Reviews"},{"key":"10.1016\/j.jsat.2016.07.014_bb0135","author":"National Institute on Drug Abuse"},{"key":"10.1016\/j.jsat.2016.07.014_bb0140","author":"National Institute on Drug Abuse"},{"key":"10.1016\/j.jsat.2016.07.014_bb0145","article-title":"Acamprosate for alcohol dependence","volume":"9","author":"R\u00f6sner","year":"2010","journal-title":"Cochrane Database Systematic Reviews"},{"key":"10.1016\/j.jsat.2016.07.014_bb0150","author":"Smith"},{"key":"10.1016\/j.jsat.2016.07.014_bb0155","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/MLR.0b013e3181c1328f","article-title":"The multiple propensity score as control for bias in the comparison of more than two treatment arms: An introduction from a case study in mental health","volume":"48","author":"Spreeuwenberg","year":"2010","journal-title":"Medical Care"},{"key":"10.1016\/j.jsat.2016.07.014_bb0160","series-title":"Results from the 2012 national survey on drug use and health: Summary of national findings, NSDUH series H-46, HHS publication no. (SMA) 13-4795","author":"Substance Abuse and Mental Health Services Administration","year":"2013"},{"key":"10.1016\/j.jsat.2016.07.014_bb0165","author":"U.S. Department of Health and Human Services"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547216300174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547216300174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:44:53Z","timestamp":1760039093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547216300174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":33,"alternative-id":["S0740547216300174"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2016.07.014","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Naturalistic Evaluation of Extended-Release Naltrexone in Clinical Practice in Missouri","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2016.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}